Ratings by JPMorgan (Tycho W. Peterson)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/15/2025 | Natera | NTRA | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/15/2025 | Charles River Labs | CRL | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/15/2025 | Bruker | BRKR | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/25/2025 | Natera | NTRA | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/7/2025 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2025 | Charles River Labs | CRL | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/29/2025 | IQVIA Holdings | IQV | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/9/2025 | Waters Corp. | WAT | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/9/2025 | Thermo Fisher Scientific | TMO | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/8/2025 | Natera | NTRA | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/7/2025 | Charles River Labs | CRL | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/5/2025 | Twist Bioscience | TWST | Maintain | Underweight (N/A) |
|
Details | ||
| 8/5/2025 | Bruker | BRKR | Maintain | Overweight (N/A) |
|
Details | ||
| 5/19/2025 | IQVIA Holdings | IQV | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/8/2025 | Bruker | BRKR | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/7/2025 | Waters Corp. | WAT | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/6/2025 | Twist Bioscience | TWST | Maintain | Underweight (Underweight) |
|
Details | ||
| 4/23/2025 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 4/22/2025 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 3/6/2025 | Waters Corp. | WAT | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/20/2025 | Charles River Labs | CRL | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/18/2025 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 2/4/2025 | Twist Bioscience | TWST | Maintain | Underweight (Underweight) |
|
Details | ||
| 2/3/2025 | ICON plc | ICLR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/3/2025 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 1/27/2025 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 1/14/2025 | ICON plc | ICLR | Maintain | Overweight (N/A) |
|
Details | ||
| 1/14/2025 | Charles River Labs | CRL | Maintain | Neutral (N/A) |
|
Details | ||
| 11/5/2024 | Bruker | BRKR | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2024 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 11/4/2024 | Waters Corp. | WAT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/25/2024 | ICON plc | ICLR | Maintain | Overweight (N/A) |
|
Details | ||
| 9/20/2024 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2024 | Charles River Labs | CRL | Downgrade | Neutral (Overweight) |
199.96 (229.75) |
14.9% | Details | |
| 8/5/2024 | Twist Bioscience | TWST | Maintain | Underweight (N/A) |
|
Details | ||
| 8/5/2024 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 5/31/2024 | ICON plc | ICLR | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2024 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2024 | Twist Bioscience | TWST | Maintain | Underweight (N/A) |
|
Details | ||
| 4/25/2024 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/15/2024 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 2/14/2024 | Bruker | BRKR | Upgrade | Overweight (Neutral) |
70.60 (58.97) |
-16.47% | Details | |
| 2/7/2024 | Waters Corp. | WAT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/5/2024 | Twist Bioscience | TWST | Maintain | Underweight (N/A) |
|
Details | ||
| 12/20/2023 | ICON plc | ICLR | Maintain | Overweight (N/A) |
|
Details | ||
| 12/20/2023 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 12/19/2023 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 11/13/2023 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2023 | Waters Corp. | WAT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/26/2023 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/25/2023 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 10/17/2023 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/17/2023 | Waters Corp. | WAT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/17/2023 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 10/17/2023 | Bruker | BRKR | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2023 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2023 | Twist Bioscience | TWST | Maintain | Underweight (N/A) |
|
Details | ||
| 8/3/2023 | Bruker | BRKR | Maintain | Neutral (N/A) |
|
Details | ||
| 8/3/2023 | Waters Corp. | WAT | Maintain | Neutral (N/A) |
|
Details | ||
| 6/16/2023 | Bruker | BRKR | Maintain | Neutral (N/A) |
|
Details | ||
| 5/25/2023 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/22/2023 | Catalent | CTLT | Downgrade | Neutral (Overweight) |
32.14 (63.48) |
97.51% | Details | |
| 5/15/2023 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 5/12/2023 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2023 | Waters Corp. | WAT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/10/2023 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2023 | Bruker | BRKR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/26/2023 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2023 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2023 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2023 | Catalent | CTLT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2023 | Waters Corp. | WAT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/6/2023 | Twist Bioscience | TWST | Maintain | Underweight (N/A) |
|
Details | ||
| 2/2/2023 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 1/25/2023 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2022 | ICON plc | ICLR | Maintain | Overweight (N/A) |
|
Details | ||
| 11/2/2022 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 11/2/2022 | Waters Corp. | WAT | Maintain | Neutral (N/A) |
|
Details | ||
| 11/2/2022 | Catalent | CTLT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/27/2022 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/21/2022 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 10/18/2022 | Syneos | SYNH | Downgrade | Neutral (Overweight) |
46.76 (42.98) |
-8.08% | Details | |
| 8/16/2022 | Rapid Micro Biosystems Inc | RPID | Downgrade | Neutral (Overweight) |
3.98 (2.01) |
-49.5% | Details | |
| 8/10/2022 | Singular Genomics | OMIC | Downgrade | Neutral (Overweight) |
4.45 (20.01) |
349.66% | Details | |
| 8/3/2022 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2022 | Rapid Micro Biosystems Inc | RPID | Maintain | Overweight (N/A) |
|
Details | ||
| 4/28/2022 | ICON plc | ICLR | Maintain | Overweight (N/A) |
|
Details | ||
| 3/3/2022 | Singular Genomics | OMIC | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2021 | Catalent | CTLT | Maintain | Overweight (N/A) |
|
Details | ||
| 9/27/2021 | ICON plc | ICLR | Upgrade | Overweight (Neutral) |
281.46 (144.96) |
-48.5% | Details | |
| 8/17/2021 | Sophia Genetics SA | SOPH | New Coverage | Overweight (N/A) |
18.00 (5.72) |
-68.22% | Details | |
| 8/9/2021 | Syneos | SYNH | Maintain | Overweight (N/A) |
|
Details | ||
| 8/9/2021 | Rapid Micro Biosystems Inc | RPID | New Coverage | Overweight (N/A) |
24.80 (2.01) |
-91.9% | Details | |
| 7/28/2021 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 7/27/2021 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 7/22/2021 | ICON plc | ICLR | Maintain | Neutral (N/A) |
|
Details | ||
| 7/22/2021 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 6/21/2021 | Singular Genomics | OMIC | New Coverage | Overweight (N/A) |
24.24 (20.01) |
-17.45% | Details | |
| 5/5/2021 | Bruker | BRKR | Maintain | Neutral (N/A) |
|
Details | ||
| 5/4/2021 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 4/28/2021 | PPD Inc. | PPD | Downgrade | Neutral (Overweight) |
46.29 (47.30) |
2.18% | Details | |
| 4/22/2021 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 4/22/2021 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 4/12/2021 | Luminex | LMNX | Upgrade | Neutral (Underweight) |
32.95 (18.70) |
-43.25% | Details | |
| 4/1/2021 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 2/18/2021 | Syneos | SYNH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/17/2021 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2021 | Bruker | BRKR | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2021 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 2/5/2021 | Twist Bioscience | TWST | Downgrade | Underweight (Neutral) |
189.96 (90.35) |
-52.44% | Details | |
| 2/2/2021 | Catalent | CTLT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/2/2021 | Waters Corp. | WAT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/1/2021 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2021 | Oxford Immunotec | OXFD | Downgrade | Neutral (Overweight) |
17.29 (21.99) |
27.18% | Details | |
| 11/25/2020 | Renalytix AI Plc. | RNLX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/23/2020 | Twist Bioscience | TWST | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2020 | Luminex | LMNX | Maintain | Underweight (N/A) |
|
Details | ||
| 11/5/2020 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2020 | Quidel Corp. | QDEL | Maintain | Underweight (N/A) |
|
Details | ||
| 8/31/2020 | Catalent | CTLT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/20/2020 | Thermo Fisher Scientific | TMO | New Coverage | Overweight (N/A) |
417.30 (528.51) |
26.65% | Details | |
| 8/18/2020 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2020 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2020 | PPD Inc. | PPD | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2020 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2020 | Oxford Immunotec | OXFD | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2020 | Catalent | CTLT | Maintain | Overweight (N/A) |
|
Details | ||
| 3/9/2020 | Varian Medical | VAR | Maintain | Underweight (N/A) |
|
Details | ||
| 2/20/2020 | ICON plc | ICLR | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2020 | Syneos | SYNH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/20/2020 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/12/2020 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2020 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 10/23/2019 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details |
